濮阳东方医院男科治疗阳痿非常便宜濮阳东方医院做人流评价好很专业,濮阳东方医院男科治早泄口碑比较好,濮阳东方看男科病评价,濮阳东方男科医院评价比较高,濮阳东方医院割包皮手术便宜吗,濮阳东方看妇科技术非常哇塞,濮阳东方医院治疗阳痿评价好收费低

SAN DIEGO (KGTV) -- As rain continues to soak California, the state is almost entirely out of a drought. According to the U.S. Drought Monitor's most recent report out Thursday, the only part of the state still experiencing any form of drought is a portion of extreme Northern California. As seen in the image below, those counties are only in a "moderate drought," the lowest level in the rating system. RELATED: Devastating 'ARk' storm envisioned for California by U.S. Geological Survey 497

SAN DIEGO (KGTV) — Currently, there are five vaccines that kids in California must get to attend school, and a lot of parents are wondering if the eventual COVID-19 vaccine will be added to that list.A website run by the California Department of Public Health seems to suggest that a change to the state’s immunization requirements may be imminent. In a message titled “COVID-19 Update,” state officials say immunization requirements “remain in place for now. Any updates will be posted here.”But history and medical science suggest it will take time before states make a COVID vaccine mandatory for children, according to Dr. Rahul Gupta, the chief medical and health officer at March of Dimes.SEE ALSO: States have authority to fine or jail people who refuse coronavirus vaccine, attorney saysMarch of Dimes is the non-profit organization that funded the search for a polio vaccine in the 1950s.“We’re seeing a repeat of history in so many ways,” Dr. Gupta said.Fear of the deadly polio virus prompted quarantines, social distancing and a run on breathing machines. In those days, doctors used iron lungs.With funding from March of Dimes, Dr. Jonas Salk launched a massive clinical trial on 1.8 million kids using his experimental vaccine in 1954. Almost exactly a year later, in April 1955, he announced the vaccine was safe and effective.Within days, five million kids got the first dose of Salk’s vaccine. But the State of California did not mandate the polio vaccine for children entering schools for six more years -- in 1961.The most recent vaccine added to California’s required immunization list was for chickenpox in 2000. That was five years after that vaccine became available in the U.S.When a COVID-19 vaccine is ready in the U.S., children will not be among the first inoculated, Dr. Gupta said. Unlike polio, the novel coronavirus tends to spare children from the most severe symptoms.“The supply will require us to make sure that we prioritize the highest risk population, including healthcare workers,” he said.It’s also unclear how children would respond to the COVID-19 vaccine. Current vaccine candidates against the coronavirus are being tested on adults not children, according to CDPH, and children mount different immune responses than adults.Experimental vaccines can also have difficulties in the production process. In the infamous Cutter Incident, one of the six labs licensed to produce the polio vaccine accidentally let live virus slip into the shots, leading to more than 250 cases of polio, including instances of paralysis and deaths.The incident prompted sweeping safety changes in the U.S.Dr. Gupta said the Cutter Incident shows vaccines need to be rolled out carefully.“We have to understand that that’s a process and we learn as we go along,” he said. “There could be some adverse events that happen from any drug, much less a vaccine that you take. Foods give you allergies. It’s not an unknown side effect.”State officials could a new vaccine to California’s mandatory list by passing a bill or through a regulation issued by CDPH.The process can often take years, but CDPH said in an emergency the process could be “greatly accelerated.” 3189

SAN DIEGO (KGTV) -- As an active 45-year-old man who loves to surf and take adventures with his daughter, Bryce Olson was the last person his friends expected to get cancer.In 2014, a call while at work confirmed it: stage IV metastatic prostate cancer.Metastatic means the cancer has spread to other parts of the body, lymph nodes, bones or other organs.“It was just shocking and sad and I didn’t know anything about this stuff, so I just...I rolled into whatever my doctors were recommending," said Olson.He says the standard of care - surgery, chemotherapy, and the initial hormone therapy - wasn't working.“I started coming to terms with my own mortality. I didn’t even think I’d see my kid get out of elementary school and I was losing hope," said Olson.Olson says he wanted to make his final days count. The Intel employee started learning about precision medicine and eventually pursued DNA sequencing to find out exactly what was driving his disease.“I'm a believer in profiling your tumor at a molecular level and trying to understand what’s driving your unique disease, and then taking that data and then finding the right drug for the right person at the right time," said Olson.His results led him to a clinical trial in Los Angeles, where he was a perfect molecular match for the drug being tested.Four years later, Olson's precision medicine journey led him to San Diego's Epic Sciences.“We're actually going to a place where no test has gone before," said Murali Prahalad, President and CEO of Epic Sciences. "These are metastatic patients; the disease has already spread. And we’re trying to understand in the later stages of the disease when it’s far more complicated, how do you then understand which treatment is the right one.”Patients like Olson have two treatment options, chemotherapy or hormone therapy."It's very important to know which medicine is going to work," said Pascal Bamford, Chief Scientific Officer of Epic Sciences, "At the metastatic end of this disease every week, every day, every month is critically important."The company has created a blood test to make the choice easier, called the Oncotype DX AR-V7 Nucleus Detect.If the antigen AR-V7 is detected in a patient, they have built a resistance to hormone therapy, meaning chemotherapy would likely be a better treatment option.“We think it’s very groundbreaking, to say this is the first test that can tell a patient which drug to go on to extend their life," said Ryan Dittamore, Chief of Medical Innovation.Dittamore says the test helps provides certainty for doctors. Patients they've studied have almost doubled their life expectancy with the AR-V7 test.“It can mean the world, not only to patients but loved ones," said Dittamore.Olson was AR-V7 negative, meaning he could continue hormone therapy.Four months in, it's working. “I’m going to see my kid not only get out of high school but college and get married. I’m fully confident that I can do that because I’m just going to keep pushing," said Olson.In December 2018 the AR-V7 test will be covered by Medicare, meaning thousands of more men will have access to it. 3150

SAN DIEGO (KGTV) - Border agents have seen a huge drop in traffic along the San Diego Sector ports of entry since the Trump Administration restricted all non-essential travel at the U.S.-Mexico border last Friday.In a conference call with reporters on Monday morning, U.S. Customs and Border Protection (CBP) revealed new details about its plan to handle the implications of the restrictions on the migrant population and the cross-border worker population. Recent tweets posted by CBP showed empty ports of entry. “We have seen about a 70% decrease on average at all our ports of entry,” said a CBP spokesperson during Monday’s conference call. That plunge in foot and vehicle traffic comes after the border restrictions took effect on Saturday.CBP said Monday that the restrictions don't apply to U.S. citizens, legal permanent residents or those traveling for medical, work or educational purposes.The agency reports that people’s work verification or documentation is currently on a sort of “honor system”. “At this point in time, we are not formally asking for verification or employment ID,” said a spokesperson on Monday.A spokesperson also reaffirmed that most apprehended migrants will be returned immediately, adding in part, “Individuals are no longer being held in detention areas.Quick interviews will be conducted in the field. Basic biographic scans run in the field as well. Then the individual will be [taken] back to the border and expelled to the country they came from.”There's now at least a 48-hour suspension on migrants crossing for court hearings, said a CBP spokesperson, who added that all new asylum seekers will be reviewed independently. “We're taking each case, case by case, depending on what the claim is, the nationality and the country from which they come from,” he added.“I'm particularly concerned about the asylum migrancy [population],” said Rafael Fernández de Castro, a U.S.-Mexico relations expert at UC San Diego. “In the shelters in Tijuana, sometimes there's 15, 20 [or even] 40 people sleeping in a room. That's basically a horrible story because that's a way to get a lot of migrants contaminated with coronavirus,” he added in his interview with 10News. CBP also reported that it’s making sure its officers have the necessary personal protective equipment like masks and gloves. 2335

SAN DIEGO (KGTV) — As Pfizer’s COVID-19 vaccine begins circulating, there is another big logistical challenge ahead: reminding people to get the second dose.Both vaccines developed by Pfizer and Moderna require two doses spaced several weeks apart. People who get immunized often feel fatigue or soreness shortly after the shot and may experience fever, particularly after the second dose, according to clinical trial data.Doctors say those immediate, short-term side effects are a positive sign the immune system is revving up production.The side effects are similar to that of the shingles vaccine. But studies show about 20 percent of the people who get the shingles vaccine skip the second dose.Experts say if that happens with the COVID vaccines, there could be consequences.The worst-case-scenario is that skipping the second shot could allow the virus to spread and mutate, and potentially build resistance to the vaccines, according to Penn State University biologist David Kennedy.That outcome is considered unlikely, but the World Health Organization announced Monday it detected a new variation of the virus in England, showing the virus is already mutating without the evolution pressure of a mass vaccine program.“Does this make the virus more serious? Does it allow the virus to transmit more easily? Does it interfere with diagnostics? Would it interfere with vaccine effectiveness? These are questions. None of these questions have been addressed yet,” said Dr. Michael Ryan, director of the WHO Health Emergencies Program.When administered in two doses, Pfizer’s vaccine is 95 percent effective at preventing COVID-19 symptoms. The FDA’s review showed the vaccine could be up to 52 percent effective after a single dose, but the data was limited.“I think you could probably say you’re going to have short-lived but incomplete protection,” said vaccine expert Dr. Paul Offit. “Protection from disease but possibly not asymptomatic shedding.”It remains unclear whether people who are fully immunized against the virus can still spread it to others asymptomatically but someone who is only partially immunized may be especially prone to silent spread, according to Offit.When Americans roll up their sleeves to get the COVID-19 vaccine, they’ll get a 4 by 6 inch index card from the CDC noting which brand they got, the lot number, and when they’re due for the second shot.People who get Pfizer’s vaccine need to get a second shot 21 days later. People who get Moderna’s need to wait 28 days for round two.The CDC is encouraging people to photograph their card with their cell phone as a backup, because beyond the index card, the logistics of reminding people about their second dose will vary by state and healthcare provider.In California’s draft vaccination plan from October, the state said it was exploring ways to "systematically text, email, and/or auto-call individuals when their second dose is needed." The California Department of Public Health did not immediately respond to a request for comment about its latest plans.Much of the work may fall to the healthcare providers who administer the shots. Although the vaccine will be free for individuals, the government is paying providers for every first dose they give and for every second dose, a way to incentivize providers to keep close tabs on patients.However, only about 25 percent of the nation’s vaccination providers have systems that can send automated reminders, according to L.J Tan, the chief strategy officer of the Immunization Action Coalition. 3552